The role of phosphoramidon on the biological activity of big endothelin-1 in the rat mesenteric microcirculation in vivo

الملخص EN

The goal of the present study was to clarify the role of metalloprotease inhibitor phosphoramidon on the effects induced by big endothelin-1 (big ET-1) in the rat mesenteric microcirculation in vivo, through investigating the systemic blood pressure, diameter and blood flow velocity of arterioles and venules of the rat mesentery.

For this purpose, the rat mesentery was arranged for in situ intravital microscopic observation under transillumination and separate cumulative injections of big ET-1 and phosphoramidon were infused into the right jugular vein, respectively.

In these experiments twenty-five rats (Charles River, 130 - 140 g) were used.

The experiments were divided into two groups.

In the first group of experiments, cumulative injections of big ET-1 (1000-8000 pmole/kg) were infused through a catheter inserted into the right jugular vein.

Each dose of big ET-1 was infused 25 min prior to the infusion of the following dose.

Infusion of big ET-1 (1000-8000 pmole/kg) elicited a long-lasting pressor effect.

The infusion of low doses of big ET-1 (1000-2000 pmole/kg) elicited a significant (p < 0.05) dose-dependent increase in the microvascular blood flow velocity both in arterioles (20 - 30 μm) and venules (30 - 50 μm), and diameters of arterioles and venules exhibited a slight not significant vasodilator effect.

The infusion of high doses of big ET-1 (4000-8000 pmole/kg) elicited significant dose-dependant decrease in the blood flow velocity of arterioles and venules, and diameters returned to the control runs.

This may be attributed to the gradual conversion of big ET-1 to ET-1, and ET-1 is a potent vasoconstrictor.

In the second group of experiments, cumulative injections of phosphoramidon (30 mg/kg /10 min) were administered 10 min prior to the infusion of big ET-1.

These findings suggested that phosphoramidon significantly suppressed long-lasting pressor effect, dose-dependent increase, dose-dependent decrease and slow vasodilator effect produced by big ET-1 in the rat mesenteric microcirculation, i.e., phosphoramidon markedly decreased the activity of endothelin-converting enzymes (ECE), which converts big ET-1 to ET-1 in the rat mesenteric microcirculation.